What is Instadose Pharma Corp. (INSD) stock price today?

Instadose Pharma Corp. (INSD) is currently trading at $0.00.

What is INSD P/E ratio?

Instadose Pharma Corp.'s P/E ratio is -0.02. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is INSD return on equity (ROE)?

Instadose Pharma Corp.'s return on equity (ROE) is 503.52%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is Instadose Pharma Corp.'s market cap?

Instadose Pharma Corp. has a market capitalization of $53193.

OTC · Drug Manufacturers - Specialty & Generic

Instadose Pharma Corp. (INSD) Stock

$0.00 OTC: INSD Healthcare

Founded in 2017 and based in Burlington, Canada, Instadose Pharma Corp. specializes in the international cultivation, processing, and distribution of pharmaceutical-grade cannabinoid oil.

Valuation

Metric	Value
Price	$0.00
Market Cap	$53193
P/E Ratio	-0.02
P/B Ratio	-0.06
P/S Ratio	0.00
EPS (TTM)	$0.00
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	503.52%
ROA	—
ROCE	372.55%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.00
Current Ratio	0.00

Annual Financials (USD)

Metric	2017	2018	2019	2020	2021
Revenue	$0	$0	$0	$0	$0
Operating Profit	$0	$0	$0	$0	$0
Net Profit	$0	$0	$0	$0	$-1.0M
EPS	$0.00	$0.00	$0.00	$0.00	$0.00
Op Margin	—	-653.0%	—	—	—

Balance Sheet (USD)

Metric	2017	2018	2019	2020	2021
Total Assets	$0	$0	$0	$0	$0
Total Liabilities	$0	$0	$0	$0	$0
Cash	$0	$0	$0	$0	$0
Borrowings	$0	$0	$0	$0	$0

Cash Flow (USD)

Metric	2017	2018	2019	2020	2021
Operating Cash Flow	$0	$0	$0	$0	$0
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$0	$0	$0	$0	$0
Free Cash Flow	$0	$0	$0	$0	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.53
FCF Yield	-0.16%
Quick Ratio	0.00
Interest Coverage	0.00
Return 1Y	-90.91%
Return 3Y	-90.91%
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ATTBFAbattis Bioceuticals Corp.	$0.00	—	-0.01	$14334	0.00%
BIOIFBiome Grow Inc.	$0.00	—	-0.01	$56208	0.00%
CBGLCannabis Global Inc.	$0.00	—	-3.40	$56821	0.00%
HENCHero Technologies Inc.	$0.00	—	-0.08	$55269	0.00%
ISOLFIsodiol International Inc.	$0.00	—	0.00	$4914	0.00%

About Instadose Pharma Corp.

Founded in 2017 and based in Burlington, Canada, Instadose Pharma Corp. specializes in the international cultivation, processing, and distribution of pharmaceutical-grade cannabinoid oil.

Instadose Pharma Corp. (INSD) stock trades at $0.00 with a market capitalization of $53193. The stock is valued at a price-to-earnings (P/E) ratio of -0.02, price-to-book of -0.06, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Instadose Pharma Corp. generates a return on equity (ROE) of 503.52% — well above the market average, a sign of a high-quality business, return on capital employed of 372.55%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.instadosepharma.com